To compare the efficacy of Nitazoxanide in a single dose of 3g VO and metronidazole in a single dose of 2g in the eradication of T. vaginalis.

ASOCIACION BENEFICA PRISMA,0 个研究点目标入组 0 人开始时间: 2002年1月14日最近更新: 2023年9月4日

适应症

试验速览

暂无简介。

•Patients 18 years of age or older, with vaginal discharge.
•Presence of mobile trichomonads in direct examination with saline or culture Positive to T. vaginalis or Polymerase Chain Reaction Test (PCR) positive for T. vaginalis in the 5 days prior to inclusion in the study.
•Written informed consent of the patient or her legal representative.
•Patients of reproductive age must also have a pregnancy test in negative urine in the 48 hours prior to the start of the clinical study.

•Diagnosis of Vulvovaginal Candidiasis by identification of pseudohyphae in
•the direct examination.
•Diagnosis of Bacterial Vaginosis by observation of clue cells in the
•direct examination.
•Having received a derivative of S-nitroimidazoIe (metronidazole, tinidazole,
•ornidazole or secnidazole) or treatment with nitazoxanide in a period of 14 days
•prior to randomization.
•History of hypersensitivity to nitazoxanide or metronidazole.
•Pregnancy.

发起方